A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy
Clinical trial NCT03362502 · TERMINATED
Trial details
- NCT number
- NCT03362502
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-23
- Primary completion
- 2022-03-28
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.